跳转至内容
Merck
CN

AB5380

一氧化氮合酶I抗体

serum, Chemicon®

别名:

NOS I, bNOS, nNOS

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
polyclonal
Application:
IHC, WB
Citations:
74
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


biological source

rabbit

Quality Level

conjugate

unconjugated

antibody form

serum

antibody product type

primary antibodies

clone

polyclonal

species reactivity

mouse, sheep, rat, human, monkey

manufacturer/tradename

Chemicon®

technique(s)

immunohistochemistry: suitable, western blot: suitable

NCBI accession no.

UniProt accession no.

shipped in

dry ice

target post-translational modification

unmodified

Gene Information

human ... NOS1(4842)

General description

161kda

Immunogen

重组人神经元型一氧化氮合酶。

Application

研究子类别
氧化应激
研究类别
神经科学
蛋白质印迹:1:1,000-1:3,000(ECL)。

免疫组化:1:1,000-1:2,000(ABC)。

最佳工作稀释度必须由最终用户进行确定。
这种一氧化氮合酶I抗体经验证可用于IH、WB检测一氧化氮合酶Ⅰ。

Biochem/physiol Actions

可识别神经元型一氧化氮合酶(nNOS、NOS-I、bNOS)。免疫组化显示与iNOS和eNOS无交叉反应。

Physical form

兔血清。 含0.05%叠氮化钠的液体。
未纯化

Preparation Note

自装运之日起在-20°C可保存6个月。等分以避免反复冻融。为了最大程度地回收产品,在融化后和取下盖子之前,将原始小瓶进行离心。

Analysis Note

对照
脑组织

Other Notes

替代:AB1552
浓度:请参考批次特异性浓缩物的检验报告。

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。


Still not finding the right product?

Explore all of our products under 一氧化氮合酶I抗体

或者

试用我们的 产品选型工具 工具缩小选择范围


存储类别

10 - Combustible liquids

wgk

WGK 1



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容

"Redox reactions are powerful chemical processes that involve the reduction and oxidation of proteins and metabolites found in living things. The mechanisms that regulate them are key to maintaining homeostasis and the balance between good health and disease pathology. Oxidative stress is the state where the delicate balance of redox biology is upset, and the pathology of oxidative stress are the cellular consequences to such an imbalance."

"Aging: getting older, exhibiting the signs of age, the decline in the physical (and mental) well-being over time, leading to death. Since the beginning of time, man has been obsessed with trying to slow down, stop, or even reverse the signs of aging. Many have gone as far as experimenting with nutritional regimens, eccentric exercises, fantastic rituals, and naturally occurring or synthetic wonder-elements to evade the signs of normal aging. Biologically speaking, what is aging? And what does the latest research tell us about the possibility of discovering the elusive “fountain of youth”? Many advances in our understanding of aging have come from systematic scientific research, and perhaps it holds the key to immortality. Scientifically, aging can be defined as a systems-wide decline in organismal function that occurs over time. This decline occurs as a result of numerous events in the organism, and these events can be classified into nine “hallmarks” of aging, as proposed by López-Otin et al. (2013). Several of the pathologies associated with aging are a direct result of these events going to extremes and may also involve aberrant activation of proliferation signals or hyperactivity. The hallmarks of aging have been defined based on their fulfillment of specific aging related criteria, such as manifestation during normal aging, acceleration of aging if experimentally induced or aggravated, and retardation of aging if prevented or blocked, resulting in increased lifespan. The nine hallmarks of aging are genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. The biological processes underlying aging are complex. By understanding the hallmarks in greater detail, we can get closer to developing intervention strategies that can make the aging process less of a decline, and more of a recline."


Estrogen induces nitric oxide production via activation of constitutive nitric oxide synthases in human neuroblastoma cells.
Xia, Y; Krukoff, TL
Endocrinology null
An association of multiple endocrine neoplasia 2B, a RET mutation; constipation; and low substance P-nerve fiber density in colonic circular muscle.
Sebastian K King, Bridget R Southwell, John M Hutson
Journal of Pediatric Surgery null
In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors.
M Victoria Puig,Noemi Santana,Pau Celada,Guadalupe Mengod,Francesc Artigas
Cerebral Cortex (1991)



全球贸易项目编号

货号GTIN
AB538004053252468889